Multiple endocrine neoplasia type 1
Abstract
The co-occurrence of parathyroid hyperplasia with pancreatic endocrine tumours and/or pituitary adenoma is classified as Multiple Endocrine Neoplasia type 1 (MEN-1) and is caused by a germ-line mutation in MEN-1 gene encoding a tumour suppressor protein, menin. This review presents clinical expressions, diagnosis and management of the MEN-1 syndrome. Properties and mechanisms of menin functions are also reviewed.
Keywords: MEN-1, Menin, Primary hyperparathyroidism, Gastrinoma, Insulinoma, Pituitary tumours
PII: S0953-6205(07)00262-2
doi:10.1016/j.ejim.2007.08.004
© 2007 Published by Elsevier Inc.
